71P Real-world treatment patterns and clinical outcomes for patients who received sintilimab (Sint) in first-line treatment of advanced non-small cell lung cancer (NSCLC) in China: A multicenter retrospective observational study

Y. Yu, L. Shang, Q. Xie,K. Ying, B. Jin, L. Zhang, L. Liu, J. Li, W. Ding

Immuno-Oncology and Technology（2022）

引用 0|浏览2

暂无评分

摘要

Sint has been used to treat patients (pts) with advanced NSCLC. This observational study aims to describe the real-world use of Sint and to explore its real-world effectiveness in the first-line (1L) treatment of advanced NSCLC.

查看译文

关键词

sintilimab,sintilimab,clinical outcomes,real-world,first-line,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要